Showing results (201-210 of 273) with videos related to
Sort By:
Pageof 28
Oncogene|January 24, 2017
RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinomaY Liu-Chittenden, M Jain, K Gaskins, et al.American Journal of Public Health|June 1, 1995
The screening histories of women with invasive cervical cancer, ConnecticutD T Janerich, O Hadjimichael, P E Schwartz, et al.Cancer Research|November 1, 1995
Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomasR F Chuaqui, J Sanz-Ortega, C Vocke, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|February 14, 2017
Implementing standardized performance indicators to improve hypertension control at both the population and healthcare organization levelsNorm Campbell, Pedro Ordunez, Marc G Jaffe, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|April 30, 2020
Blood pressure measurement device selection in low-resource settings: Challenges, compromises, and routes to progressTammy M Brady, Raj Padwal, Drew E Blakeman, et al.The American Journal of Cardiology|October 3, 2015
Metabolic Dyslipidemia and Risk of Coronary Heart Disease in 28,318 Adults With Diabetes Mellitus and Low-Density Lipoprotein Cholesterol <100 mg/dlJamal S Rana, Jennifer Y Liu, Howard H Moffet, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|May 1, 1992
Role of tumor necrosis factor in oxygen toxicityJ C Jensen, H W Pogrebniak, H I Pass, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|September 24, 2019
Scaling up effective treatment of hypertension-A pathfinder for universal health coverageThomas R Frieden, Cherian V Varghese, Sandeep P Kishore, et al.Journal of the American Heart Association|April 28, 2020
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and AffordabilityMuhammad Jami Husain, Biplab Kumar Datta, Deliana Kostova, et al.Human Pathology|February 24, 2000
Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behaviorC N Otis, P A Krebs, M M Quezado, et al.Pageof 28